Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liberal versus restrictive hydroxyethyl starch strategy in cardiac surgery
KCT0012883Phase 4Not yet recruiting
- Sponsor
- Asan Medical Center
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hetastarch in cardiac surgery, sponsored by Asan Medical Center. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
hetastarch
03
Conditions
cardiac surgery
Beyond the preview
Go deeper on KCT0012883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0012883.